Effects of Inspiratory Muscle Training and Positive Expiratory Pressure on Mechanically Ventilated Restrictive Lung Disease Patients
1 other identifier
interventional
30
1 country
3
Brief Summary
Restrictive lung diseases (RLD) represent a significant cause of morbidity, often necessitating intensive interventions such as mechanical ventilation due to diminished lung compliance (LC) and reduced total lung capacity (TLC). Mechanical ventilation, while vital, is associated with ventilator-induced diaphragmatic dysfunction (VIDD), leading to rapid muscle atrophy and impeding patient recovery. This proposed study aims to evaluate the clinical impact of IMT and PEP on improving respiratory muscle strength, lung compliance and mobilizing secretions (effective cough reflex) in patients with RLD who require mechanical ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 9, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
October 9, 2026
October 1, 2026
1.2 years
July 9, 2026
October 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lung compliance
It will be assessed daily using ventilator-derived parameters. Static and dynamic compliance values will be recorded directly from the ventilator settings, providing objective measures of lung mechanics improvements throughout the intervention period.
From randomization until extubation, or completion of the 7-day intervention period, whichever occurs first; assessed twice daily, up to 7 days
Study Arms (2)
Conventional Physiotherapy
ACTIVE COMPARATORParticipants in the group A will recieve standard physiotherapy, including passive/active limb exercises, chest percussion, and positioning. Each session will last for 15 minutes.
Conventional Physiotherapy Plus Inspiratory Muscle Training and Positive Expiratory Pressure
EXPERIMENTALParticipants in Group B will recieve standard physiotherapy along with targeted inspiratory and positive expiratory pressure (PEP) muscle training to enhance respiratory muscle strength.
Interventions
Inspiratory Muscle Training (IMT): Patients will be positioned at a 45° angle in bed. The IMT device will be individually calibrated and connected to the endotracheal tube. Initial intensity will be set at 40% of the patient's maximal inspiratory pressure (MIP), progressing daily by 10%. Positive Expiratory Pressure (PEP) Training: Patients will be positioned laterally. The PEP device will be set at 7 cm H₂O resistance and will be connected to the endotracheal tube. Training will continue daily. Sessions will be paused if signs of respiratory or hemodynamic instability appear (e.g., altered respiratory rate, SpO₂, BP, HR, mental status, hemoptysis, arrhythmias, or diaphoresis). In such cases, training intensity will be maintained at the previous level.
Participants will receive standard physiotherapy consisting of passive and active range-of-motion exercises for the upper and lower limbs, chest physiotherapy (including chest percussion), and therapeutic positioning. Each treatment session will last 15 minutes and will be administered by a qualified physiotherapist according to the institutional standard of care.
Eligibility Criteria
You may qualify if:
- Patients aged between 18 and 60 years.
- Diagnosed with restrictive lung disease (RLD), including interstitial lung diseases, idiopathic pulmonary fibrosis, chest wall deformities, or neuromuscular diseases.
- Admitted to the ICU and requiring invasive mechanical ventilation for more than 48 hours.
- Glasgow Coma Scale score over 13, inspiratory pressures below -20 cmH2O, oxygen saturation above 90%, tidal volumes exceeding 5ml/kg, respiratory rates under 35 breaths per minute
- Hemodynamically stable at the time of enrolment (as determined by the treating physician).
You may not qualify if:
- Pre-existing chronic obstructive pulmonary disease (COPD) or other primary obstructive pathologies.
- Hemodynamic instability (e.g., requiring high-dose vasopressors).
- Active pneumothorax or untreated bronchopleural fistula.
- History of cranial or facial trauma, recent thoracic or abdominal surgery contraindicating the intervention.
- Pre-existing cognitive impairment or inability to comprehend and cooperate with the training protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Foundation University College of Physical Therapy Islamabad
Islamabad, Pakistan
Foundation University College of Physical Therapy Islamabad
Rawalpindi, Pakistan
Foundation University College of Physical Therapy Islamabad
Rawalpindi, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2026
First Posted
October 9, 2026
Study Start
December 1, 2025
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
January 31, 2027
Last Updated
October 9, 2026
Record last verified: 2026-10